Mirvie Granted Breakthrough Device Designation For Test To Identify Risk Of Preeclampsia
Mirvie’s RNA platform can identify 75% of women who develop preeclampsia months before symptoms occur.
You may also be interested in...
Smith + Nephew is expanding its suite of simulation technologies to train surgeons on new techniques before they enter the operating room.
In his recent report on Alcon, BTIG analyst Ryan Zimmerman estimated that its pharmaceutical portfolio could generate close to $900m in fiscal year 2022.
Aidoc’s AI-based software is integrated in more than 1,000 medical centers. The company has raised a total of $250m in VC money, which will be used to expand its technology beyond radiology.